Back to top

LICENSE & DISTRIBUTION AGREEMENT

Distribution Agreement

LICENSE & DISTRIBUTION AGREEMENT | Document Parties: E MED FUTURE INC | ITDEVELOPMENT SOLUTIONS, INC You are currently viewing:
This Distribution Agreement involves

E MED FUTURE INC | ITDEVELOPMENT SOLUTIONS, INC

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: LICENSE & DISTRIBUTION AGREEMENT
Governing Law: Ohio     Date: 9/20/2004

LICENSE & DISTRIBUTION AGREEMENT, Parties: e med future inc , itdevelopment solutions  inc
50 of the Top 250 law firms use our Products every day

Exhibit 10.1

 

LICENSE & DISTRIBUTION AGREEMENT

 

This LICENSE & DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of the 16 th day of September, 2004, by and among E MED FUTURE, INC ., a corporation organized and existing under the laws of the State of Nevada, United States of America (“Licensor”) and ITDEVELOPMENT SOLUTIONS, INC . a corporation organized and existing under the laws of the state of Florida (“Licensee”).

 

WHEREAS , Licensor is engaged in the development, manufacture and licensing of medical equipment destruction and waste disposal devices, including a proprietary technology to manufacture a portable medical device that incinerates aluminum, stainless steel, and other metallic hypodermic needles (hereinafter “licensor technology”), has applied for patents, has developed know-how in connection therewith, has registered the trademark “NeedleZap ® ” for the medical device in the United States of America (hereinafter “United States”) and other countries (hereinafter “licensor trademark rights”), and is seeking a licensee to utilize licensor technology outside of the United States (the “product”).

 

WHEREAS , Licensor has the right to grant the license rights described herein under Licensor Technology, including the Applications for Letters Patent as listed in Schedules A and B, attached hereto and made a part of this Agreement, and as amended and updated from time to time (hereinafter “licensor patent rights”), and the right to grant the license rights to use licensor trademark rights, listed in Exhibit “A”, attached hereto and made a part of this Agreement, and as amended and updated from time to time; and

 

WHEREAS , Licensee is in the business of manufacturing and selling various types of consumer products and equipment and desires to obtain a license and right to manufacture the Product for Licensor for worldwide distribution and to distribute and sell the Product in Pakistan and the United Arabs Emirates (“Licensed Territories”); and

 

WHEREAS, Licensor has granted access to certain Licensor Technology, patent and license information, trade secrets, and other materials to evaluate its Product under a Non Disclosure Agreement; and

 

WHEREAS , Licensor desires to grant an exclusive license and right to permit Licensee to manufacture or to contract to have manufactured Licensed Products in the Licensed Territories according to Licensor Technology under Licensor Patent Rights, to grant licensee the exclusive right to distribute and to sell Licensed Products in the Licensed Territories, and to grant an exclusive license and right to use Licensor Trademark Rights in connection with the distribution and sale of Licensed Products in the Licensed Territories.


NOW, THEREFORE , in consideration of the terms, covenants and conditions contained herein, the parties hereto mutually agree as follows:

 

 

1)

Grant to Manufacture and Distribution Rights .

 

 

(a)

Licensor hereby grants to Licensee, and Licensee hereby accepts, for the term of and under the provisions of this Agreement the right and license (i.) to use Licensor Technology under Licensor Patent Rights in order to manufacture or to contract to manufacture the Product and (ii.) to distribute and sell the Product in the Licensed Territories. Licensee may contract with sublicensees and agents to distribute and sell the Product within the Licensed Territories. Each sublicensee or agent shall be identified in writing to Licensor by Licensee . Licensee agrees that it will not distribute, manufacture, sell or market either directly or indirectly the Product outside of the Licensed Territories.

 

 

(b)

The license granted hereby may not be transferred or sublicensed by Licensee, except to the extent permit herein, but shall extend to any wholly-owned subsidiaries and divisions of Licensee. Licensee shall be responsible for the compliance by each such subsidiary and division, sublicense and agent with the terms and provisions of this Agreement, and agrees to report and pay royalties to Licensor in accordance with Section 3 hereof with respect to production of the Product by each such subsidiary or division, sublicense and agent. Any such affiliate shall agree in advance in writing to be bound by all the terms of this Agreement, and Licensee shall agree to guarantee the obligations of such assignee hereunder.

 

 

(c)

The license granted hereby conveys no right to Licensee to use or register any trademark or trade name of Licensor, or to use the name of Licensor or any trademark or trade name in any manner whatsoever in connection with the sale of the Product hereunder. Nothing in this Agreement shall be construed as conveying, expressly or by implication, any right under any of Licensor’s know-how except in connection with the manufacture and sale of the Product hereunder.

 

 

(i.)

In the event that the NeedleZap TM trademark cannot be utilized in the Licensed Territories for legal, cultural, or other reasons, and Licensee determines to create a brand for the distribution and sale of the Product, all such brands shall be the property of Licensor; Licensee shall notify Licensor of its inability to utilize existing brand and request Licensor’s approval to utilize an alternate brand. Licensee must include with the request (a) a proposed budget for development and utilization of the brand and (b) copies of the proposed brand design. Licensor shall have the final decision on all brand changes to existing branding and labeling, which must remain in compliance with US laws and the protection of Licensor’s patent and intellectual property rights. In the event of termination of this Agreement not for cause by Licensor, Licensor agrees to reimburse Licensee for the exact cost paid to develop this new “brand” name as previously approved by Licensor.

 

2


 

(ii.)

Licensee shall make application and/or register with local governmental authorities all marks or branding of the Product. Any registration of the mark or brand shall be made in the name of Licensor.

 

 

(d)

Licensee shall not have the Product manufactured for it by any third party without the prior written consent of Licensor.

 

 

(e)

Upon the termination of this license for any reason, Licensee shall return the Technology, including but not limited to all plans, manuals, FDA documentation and procedures, writings, and/or other materials provided to Licensee by Licensor at any time, and any and all copies thereof, to Licensor.

 

 

(f)

Licensee shall be the sole manufacturer of product set forth in the attachment in Pakistan and the U.A.E. Should Licensee desire to purchase FDA product for sale in Pakistan & the U.A.E. prior to obtaining FDA approval, Licensee may do so in accordance with Licensor’s international marketing agreement with Transglobal Medical.

 

 

(g)

Licensee shall establish a program of quality control to assure Licensor that all Products manufactured utilizing the Licensor Technology for Products will perform in a reasonably satisfactory manner as a medical device meeting the regulatory standards of the U.S. Food and Drug Administration (FDA) and Licensor’s quality control protocols, copies of which have been provided Licensee. Licensor will assist Licensee in obtaining approval for units manufactured in Pakistan under the FDA.

 

 

2.

Licensed Territory . The license to manufacture and sell the Product granted hereby shall be exclusive as to sales for delivery within Pakistan and the United Arab Emirates (U.A.E.). Licensee may from time to time request the right to sell the Product in other areas. If Licensor has not at the time granted to anyone else the right to sell the Product in such other areas, Licensor will grant to Licensee the non exclusive right to manufacture and sell the Product in such other areas on terms to be negotiated at that time, provided that such right shall exist only until such time as Licensor grants to Licensee or someone else an exclusive right to sell in any such area.

 

 

3.

Royalties .

 

 

(a)

In consideration of the rights and licenses granted herein to Licensor Technology to be provided to Licensee by Licensor under this Agreement, and in lieu of a sales quota until the 2006 calendar year, Licensee shall provide

 

3


10,000 NeedleZap Units without cost to Licensor together with the sum of Ninety Thousand dollars ($90,000), in addition to periodic royalties as hereinafter provided, payable by Licensee to Licensor as follows:

 

 

(i.)

Thirty thousand dollars (U.S. $30,000) within one (1) week after execution of the Memorandum, nonrefundable, such payment to be in consideration of Licensor’s agreement herein to grant exclusive territories to Licensee without a minimum order guarantee for the remainder of 2004 and 2005;

 

 

(ii.)

Thirty thousand dollars (U.S. $30,000) within four (4) weeks of execution of the Agreement, nonrefundable, and

 

 

(iii.)

Thirty thousand dollars (U.S. $30,000) within eight (8) weeks of execution of the Agreement, nonrefundable.

 

 

(b)

In further consideration of the license and rights granted and in addition to the fixed payments provided for in Section 3(a) above, Licensee shall pay to Licensor periodic royalties at the rate of fifteen dollars (U.S. $15.00) for each unit of the Product sold by Licensee within Pakistan and the UAE. Such periodic royalties shall be paid by Licensee to Licensor within thirty (30) days following the end of each fiscal quarter of this Agreement, beginning with the end of the third full month following the execution of this Agreement.

 

 

(c)

Beginning in calendar year 2006, Licensee’s Sales Quota shall be set at 50% of their 2005 calendar year total unit sales in Pakistan and the UAE (each country separately) or a minimum of 10,000 units in Pakistan and in U.A.E. combined, whichever is greater. The SALES QUOTA for the Licensed Territories shall increase by five percent (5%) after the 2006 sales year and shall increase by five percent (5%) on the anniversary date of subsequent years thereafter during the time the Agreement is in effect for the countries. Failure to meet the annual Sales Quota in either country, allows Licensor the right to terminate all exclusive sales rights within that country.

 

 

(d)

Licensee will furnish to Licensor within thirty (30) days following the end of each such quarter a written statement certified by the Chief Financial Officer of Licensee showing the number of units of the Product sold by Licensee during such quarter, and the amount of periodic royalties due for the corresponding period, together with payment of the royalties due.

 

 

(e)

Licensee will at all times during the term of this Agreement keep accurate books of account and other records reflecting all sales of the Product, and will carefully prepare and maintain such books and records for at least two (2) years following the termination of this Agreement. Licensee hereby grants to Licensor or its duly accredited representative the right to inspect and copy such books and records for the purpose of ascertaining or confirming the accuracy of statements rendered hereunder, such inspection and copying costs to be at the expense of Licensor.

 

4


 

(f)

All payments provided for in this Agreement shall be made to Licensor in United States currency. Said payments are to be made by wire as directed by Licensor under separate instruction. All payments shall be net to Licensor, without deduction for taxes, assessments, or other charges which may be imposed on Licensor by the Government of Pakistan, the U.A.E., or any other entity or any political subdivision thereof with respect to any amounts payable to Licensor pursuant to this Agreement, and without deduction for banking or wire transfer fees. Such taxes, assessments or other charges, and fees shall be paid by Licensee.

 

 

4.

Manufacturing for non-Licensed Territories and Licensor Use . Licensee agrees that it will sell to Licensor for Licensor’s purposes the products listed in the attachments and manufactured in Licensed Territories, at Licensees’ MLO (Material, Labor, Overhead) Manufacturing Cost per unit plus 20% MLO cost.

 

 

a)

The initial per unit cost shall including one AC or DC charger as specified by Licensor from time to time, and packaged for shipment at $10.75 per unit. Said pricing will be maintained for the first 100,000 units of production, not including the units supplied as part of the license, or through December 31, 2005 (whichever comes first). This per unit price is subject to minimum quantity orders of 10,000 units, with approved Financing.

 

 

b)

Licensor shall pay for any shipping, crating, handling, insurance, transportation, customs duties, taxes and other customary charges. The Licensee shall assist Licensor in obtaining any export compliance approvals necessary under Pakistani export laws and designated country of delivery import laws, the cost of which shall be borne by Licensor.

 

Nature of Manufacturing Relationship .

 

 

(a)

Nothing contained herein to the contrary shall prohibit Licensor from continuing to purchase products from its existing manufacturing relationships, manufacturing the products listed in the attachment in its own facilities, or through contractual manufacturers other than Licensee; however, Licensor warrants that it has no intent to license another non-United States, non- FDA approved manufacturing facility other than Licensee, so long as Licensee can meet quantity, quality, and competitive pricing suitable to Licensor. Licensor and Licensee acknowledge and agree that an agreement between Licensor and Providers International pre-exists this Agreement and permits Provider’s International to manufacture or cause to be manufacture the products listed in the attachments in China for sales in China and Australia by Providers International and their distributors.

 

5


 

(b)

Licensee acknowledges that Licensor is in the business of selling its products and Licensor must have the opportunity to have manufactured products at quantity, quality, and pricing levels commercially acceptable in various marketplaces around the globe. With this requirement as a condition, Licensor grants unto Licensee an exclusive license to manufacture Licensor’s non-US requirements for non-FDA approved products listed in the attachments.

 

 

i.

Licensee agrees that in the event Licensor notifies Licensee of a potential market, country, or distribution source that desires to purchase Licensor’s products, but that market, country, or distribution has quantity, quality, or pricing or non-commercial concerns with the products manufactured by Licensee, that Licensee will work with Licensor to structure an acceptable solution. If no solution can be reached, Licensor shall be permitted to explore and utilize alternative manufacturing opportunities.

 

 

ii.

Licensor agrees to assist Licensee in obtaining FDA approval for product through its Pakistan manufacturing facility. Should Licensee obtain FDA approval, Licensor agrees to purchase FDA approved products listed on the attachments from Licensee where commercially viable and available.

 

 

5.

Warranty.

 

 

a)

Product Warranties, if any, are provided by Licensee for Products it produces. Licensor makes no warranties whatsoever.

 

 

b)

IN NO EVENT SHALL LICENSOR BE LIABLE FOR ANY CONSEQUENTIAL DAMAGES OR DAMAGES OF ANY KIND OR NATURE ALLEGED TO HAVE RESULTED FROM ANY BREACH OF WARRANTY. LICENSOR DOES NOT WARRANT THE MERCHANTABILITY OF THE PRODUCTS OR THEIR FITNESS FOR ANY PARTICULAR PURPOSE. LICENSOR MAKES NO WARRANTY, EXPRESS OR IMPLIED, OTHER THAN THOSE SPECIFICALLY SET FORTH HEREIN.

 

 

c)

Licensee shall provide for Products sold to Licensor or outside Licensed territories at the request of Licensor or its representatives a one year limited warranty consisting of the following:

 

One-Year Limited Warranty

 

Licensee warrants this device to be free from defects in material and workmanship existing at the time of manufacture and appearing within one (1) year from the original date of purchase.

 

6


If such a defect appears during the warranty period, we will (at our sole option) repair or replace the defective unit with no charge for service or parts, provided that the unit is delivered at the customer’s expense to the manufacturer.

 

This warranty extends only to the original consumer purchaser and does not cover damage or claims resulting from misuse, failure to follow instructions in use, failure to replace the clean-out plug as directed, neglect, improper maintenance, use on a current or voltage other than specified for the device, or unauthorized service during the warranty period.

 

THIS WARRANTY SHALL BE EXCLUSIVE AND SHALL BE IN LIEU OF ANY OTHER EXPRESS WARRANTY, WRITTEN OR ORAL, INCLUDING BUT NOT LIMITED TO ANY EXPRESS WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. THE DURATION OF ANY IMPLIED WARRANTIES OF MERCHANTABILTY OR FITNESS FOR A PARTICULAR PURPOSE IS EXPRESSLY LIMITED TO THE PERIOD OF THIS LIMITED WARRANTY.

 

THE CUSTOMER’S EXCLUSIVE REMEDY FOR BREACH OF THIS WARRANTY OR ANY IMPLIED WARRANTY OR ANY OTHER OBLIGATION ARISING BY OPERATION OF LAW OR OTHERWISE SHALL BE LIMITED AS SPECIFIED HEREIN TO REPAIR OR REPLACEMENT, AT OUR SOLE OPTION. IN ANY EVENT, LICENSEE EXPRESSLY DISCLAIMS ALL REPONSIBILITY FOR SPECIAL, CONSEQUENTIAL, OR INCIDENTAL DAMAGES CAUSED BY THE USE OF THE DEVICE. Some jurisdictions may not allow this exclusion or limitation of incidental or consequential damages, so the foregoing disclaimer may not apply to you.

 

If you have a claim under this warranty, please call the toll free number listed below. ALL RETURNS MUST BE ASSIGNED AN RMA NUMBER PRIOR TO RETURN.

 

NUMBER TO BE ASSIGNED

 

 

d)

Defective Returns.

 

 

i.

Licensor may return to Licensee for replacement or credit any Products (other than Configured Products) found to be defective within ninety (90) days of purchase or any Configured Products which are found to be defective within thirty (30) days of purchase. Licensor must obtain Licensee’s approval prior to returning the Products. Licensee reserves the right to require Licensor to return defective Products directly to the Product


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more